What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
Haider N, et al. J Clin Invest. 2021 Sep 10:151818. doi: 10.1172/JCI151818. Online ahead of print. J Clin Invest. 2021. PMID: 34506305